Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Enzo Biochem, Inc. (ENZ)

1.96   -0.01 (-0.51%) 11-25 13:00
Open: 1.9772 Pre. Close: 1.97
High: 2.01 Low: 1.96
Volume: 4,897 Market Cap: 95(M)

Technical analysis

as of: 2022-11-25 1:56:43 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.63     One year: 2.89
Support: Support1: 1.9    Support2: 1.58
Resistance: Resistance1: 2.25    Resistance2: 2.48
Pivot: 2.15
Moving Average: MA(5): 1.98     MA(20): 2.15
MA(100): 2.32     MA(250): 2.65
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 8.7     %D(3): 5.7
RSI: RSI(14): 36.9
52-week: High: 3.7  Low: 1.9
Average Vol(K): 3-Month: 47 (K)  10-Days: 32 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ENZ ] has closed above bottom band by 18.1%. Bollinger Bands are 44.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.06 - 2.07 2.07 - 2.08
Low: 1.88 - 1.89 1.89 - 1.9
Close: 1.95 - 1.97 1.97 - 1.99

Company Description

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing 'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in Farmingdale, New York.

Headline News

Sat, 26 Nov 2022
James Wolf of Enzo Biochem, Inc. (NYSE:ENZ) Just Spent US$5.0m On Shares - Simply Wall St

Fri, 25 Nov 2022
IDP launches scholarships search feature - The PIE News

Fri, 25 Nov 2022
Australia: International student health data leaked on dark web - The PIE News

Fri, 25 Nov 2022
Canada: pandemic sees first international student decline in decade - The PIE News

Thu, 24 Nov 2022
Crowded House Bring Out Noel Crombie and Mark Seymour For Melbourne Show - Noise11

Thu, 24 Nov 2022
NZ: ENZ Asia and Latin America scholarships announced - The PIE News

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 49 (M)
Shares Float 29 (M)
% Held by Insiders 24.8 (%)
% Held by Institutions 42.1 (%)
Shares Short 403 (K)
Shares Short P.Month 387 (K)

Stock Financials

EPS -0.15
EPS Est Next Qtl -0.01
EPS Est This Year -0.02
EPS Est Next Year 0.03
Book Value (p.s.) 1.12
Profit Margin (%) -17.1
Operating Margin (%) -14.2
Return on Assets (ttm) -9.1
Return on Equity (ttm) -29.7
Qtrly Rev. Growth -18.3
Gross Profit (p.s.) 0.86
Sales Per Share 2.19
EBITDA (p.s.) -0.26
Qtrly Earnings Growth 0
Operating Cash Flow -17 (M)
Levered Free Cash Flow -15 (M)

Stock Valuations

PE Ratio -14
PEG Ratio 0
Price to Book value 1.75
Price to Sales 0.89
Price to Cash Flow -5.76

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.